Coexpression Network Analysis Identifies a Novel Nine-RNA Signature to Improve Prognostic Prediction for Prostate Cancer Patients

Figure 7

The superiority of the molecular prognostic signature to clinical indicators. (a) Stratification analysis for the Gleason score. (b) Stratification analysis for the level of prostate-specific antigen (PSA). (c) Time-dependent ROC curve analysis constructed according to various models. HR: hazard ratio; AUC: area under the receiver operator characteristic curve.

(a)

(b)

(c)